Steven Gillis, Director at VBI Vaccines Inc/BC (VBIV), bought 300,000 shares at $3.05 ($915K) on 2017-10-30, disclosed to the SEC on 2017-10-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |
| VBIV | BUY | 2023-07-18 | $2.0M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |